1,741
Views
23
CrossRef citations to date
0
Altmetric
Research Paper

Synthesis and biological evaluation of novel 3-(quinolin-4-ylamino)benzenesulfonamides as carbonic anhydrase isoforms I and II inhibitors

, ORCID Icon, , , , , , & ORCID Icon show all
Pages 1457-1464 | Received 04 Jul 2019, Accepted 31 Jul 2019, Published online: 14 Aug 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (5)

Waleed A. Badawi, Mahmoud Rashed, Alessio Nocentini, Alessandro Bonardi, Mohammad M. Abd-Alhaseeb, Sara T. Al-Rashood, Giri Babu Veerakanellore, Taghreed A. Majrashi, Eslam B. Elkaeed, Bahaa Elgendy, Paola Gratteri, Claudiu T. Supuran, Wagdy M. Eldehna & Mohamed Elagawany. (2023) Identification of new 4-(6-oxopyridazin-1-yl)benzenesulfonamides as multi-target anti-inflammatory agents targeting carbonic anhydrase, COX-2 and 5-LOX enzymes: synthesis, biological evaluations and modelling insights. Journal of Enzyme Inhibition and Medicinal Chemistry 38:1.
Read now
Amany Belal, Nagwa M. Abdel Gawad, Ahmed B. M. Mehany, Mohammed A. S. Abourehab, Hazem Elkady, Ahmed A. Al‐Karmalawy & Ahmed S. Ismael. (2022) Design, synthesis and molecular docking of new fused 1H-pyrroles, pyrrolo[3,2-d]pyrimidines and pyrrolo[3,2-e][1, 4]diazepine derivatives as potent EGFR/CDK2 inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 1884-1902.
Read now
Mohamed M. Khalifa, Ahmed A. Al-Karmalawy, Eslam B. Elkaeed, Mohamed S. Nafie, Mohamed A. Tantawy, Ibrahim H. Eissa & Hazem A. Mahdy. (2022) Topo II inhibition and DNA intercalation by new phthalazine-based derivatives as potent anticancer agents: design, synthesis, anti-proliferative, docking, and in vivo studies. Journal of Enzyme Inhibition and Medicinal Chemistry 37:1, pages 299-314.
Read now
Aleksandrs Pustenko, Alessio Nocentini, Paola Gratteri, Alessandro Bonardi, Igor Vozny, Raivis Žalubovskis & Claudiu T. Supuran. (2020) The antibiotic furagin and its derivatives are isoform-selective human carbonic anhydrase inhibitors. Journal of Enzyme Inhibition and Medicinal Chemistry 35:1, pages 1011-1020.
Read now
Mohamed A. Abdelrahman, Wagdy M. Eldehna, Alessio Nocentini, Hany S. Ibrahim, Hadia Almahli, Hatem A. Abdel-Aziz, Sahar M. Abou-Seri & Claudiu T. Supuran. (2020) Novel benzofuran-based sulphonamides as selective carbonic anhydrases IX and XII inhibitors: synthesis and in vitro biological evaluation. Journal of Enzyme Inhibition and Medicinal Chemistry 35:1, pages 298-305.
Read now

Articles from other publishers (18)

Mahmoud A. Ragab, Wagdy M. Eldehna, Alessio Nocentini, Alessandro Bonardi, Hazem E. Okda, Bahaa Elgendy, Tarek S. Ibrahim, Mohammad M. Abd-Alhaseeb, Paola Gratteri, Claudiu T. Supuran, Ahmed A. Al-Karmalawy & Mohamed Elagawany. (2023) 4-(5-Amino-pyrazol-1-yl)benzenesulfonamide derivatives as novel multi-target anti-inflammatory agents endowed with inhibitory activity against COX-2, 5-LOX and carbonic anhydrase: Design, synthesis, and biological assessments. European Journal of Medicinal Chemistry 250, pages 115180.
Crossref
Reihane Ghomashi, Shakila Ghomashi, Hamidreza Aghaei & Ahmad Reza Massah. (2023) Recent Advances in Biological Active Sulfonamide based Hybrid Compounds Part A: Two-Component Sulfonamide Hybrids. Current Medicinal Chemistry 30:4, pages 407-480.
Crossref
Afaf El-Malah, Ehab S. Taher, Andrea Angeli, Samar S. Elbaramawi, Zeinab Mahmoud, Nour Moustafa, Claudiu T. Supuran & Tarek S. Ibrahim. (2023) Schiff bases as linker in the development of quinoline-sulfonamide hybrids as selective cancer-associated carbonic anhydrase isoforms IX/XII inhibitors: A new regioisomerism tactic. Bioorganic Chemistry 131, pages 106309.
Crossref
Mohamed A. Abdelgawad, Nadia A.A. Elkanzi, Arafa Musa, Mohammed M. Ghoneim, Waqas Ahmad, Mohammed Elmowafy, Ahmed M. Abdelhaleem Ali, Ahmed H. Abdelazeem, Syed N.A. Bukhari, Mohamed El-Sherbiny, Mohammed A.S. Abourehab & Rania B. Bakr. (2022) Optimization of pyrazolo[1,5-a]pyrimidine based compounds with pyridine scaffold: Synthesis, biological evaluation and molecular modeling study. Arabian Journal of Chemistry 15:8, pages 104015.
Crossref
Samar A. El-Kalyoubi, Ehab S. Taher, Tarek S. Ibrahim, Mohammed Farrag El-Behairy & Amany M. M. Al-Mahmoudy. (2022) Uracil as a Zn-Binding Bioisostere of the Allergic Benzenesulfonamide in the Design of Quinoline–Uracil Hybrids as Anticancer Carbonic Anhydrase Inhibitors. Pharmaceuticals 15:5, pages 494.
Crossref
Baijayantimala Swain, Santosh Kumar Sahoo, Priti Singh, Andrea Angeli, Venkata Madhavi Yaddanapudi, Claudiu T. Supuran & Mohammed Arifuddin. (2022) Exploration of 2-phenylquinoline-4-carboxamide linked benzene sulfonamide derivatives as isoform selective inhibitors of transmembrane human carbonic anhydrases. European Journal of Medicinal Chemistry 234, pages 114247.
Crossref
Diaaeldin M. Elimam, Wagdy M. Eldehna, Rofaida Salem, Alessandro Bonardi, Alessio Nocentini, Sara T. Al-Rashood, Mahmoud M. Elaasser, Paola Gratteri, Claudiu T. Supuran & Heba Abdelrasheed Allam. (2022) Natural inspired ligustrazine-based SLC-0111 analogues as novel carbonic anhydrase inhibitors. European Journal of Medicinal Chemistry 228, pages 114008.
Crossref
Diaaeldin M. Elimam, Abdullah A. Elgazar, Alessandro Bonardi, Mohamed Abdelfadil, Alessio Nocentini, Ramadan A. El-Domany, Hatem A. Abdel-Aziz, Farid A. Badria, Claudiu T. Supuran & Wagdy M. Eldehna. (2021) Natural inspired piperine-based sulfonamides and carboxylic acids as carbonic anhydrase inhibitors: Design, synthesis and biological evaluation. European Journal of Medicinal Chemistry 225, pages 113800.
Crossref
Moataz Shaldam, Alessio Nocentini, Zainab M. Elsayed, Tamer M. Ibrahim, Rofaida Salem, Ramadan A. El-Domany, Clemente Capasso, Claudiu T. Supuran & Wagdy M. Eldehna. (2021) Development of Novel Quinoline-Based Sulfonamides as Selective Cancer-Associated Carbonic Anhydrase Isoform IX Inhibitors. International Journal of Molecular Sciences 22:20, pages 11119.
Crossref
Mostafa M. Elbadawi, Wagdy M. Eldehna, Alessio Nocentini, Mahmoud F. Abo-Ashour, Eslam B. Elkaeed, Mohamed A. Abdelgawad, Khalid S. Alharbi, Hatem A. Abdel-Aziz, Claudiu T. Supuran, Paola Gratteri & Mohammad M. Al-Sanea. (2021) Identification of N-phenyl-2-(phenylsulfonyl)acetamides/propanamides as new SLC-0111 analogues: Synthesis and evaluation of the carbonic anhydrase inhibitory activities. European Journal of Medicinal Chemistry 218, pages 113360.
Crossref
Mostafa M. Elbadawi, Wagdy M. Eldehna, Wenjie Wang, Keli K. Agama, Yves Pommier & Manabu Abe. (2021) Discovery of 4-alkoxy-2-aryl-6,7-dimethoxyquinolines as a new class of topoisomerase I inhibitors endowed with potent in vitro anticancer activity. European Journal of Medicinal Chemistry 215, pages 113261.
Crossref
Hossam Nada, Ahmed Elkamhawy & Kyeong Lee. (2021) Structure Activity Relationship of Key Heterocyclic Anti-Angiogenic Leads of Promising Potential in the Fight against Cancer. Molecules 26:3, pages 553.
Crossref
Mohammad M. Al-Sanea, Ahmad J. Obaidullah, Mohamed E. Shaker, Garri Chilingaryan, Mohammed M. Alanazi, Nawaf A. Alsaif, Hamad M. Alkahtani, Sultan A. Alsubaie & Mohamed A. Abdelgawad. (2021) A New CDK2 Inhibitor with 3-Hydrazonoindolin-2-One Scaffold Endowed with Anti-Breast Cancer Activity: Design, Synthesis, Biological Evaluation, and In Silico Insights. Molecules 26:2, pages 412.
Crossref
Mohammad M. Al-Sanea, Ahmed Elkamhawy, Sora Paik, Kyeong Lee, Ahmed M. El Kerdawy, Bukhari Syed Nasir Abbas, Eun Joo Roh, Wagdy M. Eldehna, Heba A.H. Elshemy, Rania B Bakr, Ibrahim Ali Farahat, Abdulaziz I. Alzarea, Sami I. Alzarea, Khalid S. Alharbi & Mohamed A. Abdelgawad. (2020) Sulfonamide-based 4-anilinoquinoline derivatives as novel dual Aurora kinase (AURKA/B) inhibitors: Synthesis, biological evaluation and in silico insights. Bioorganic & Medicinal Chemistry 28:13, pages 115525.
Crossref
Mohammad M. Al-Sanea. (2020) Synthesis and biological evaluation of small molecule modulators of CDK8/Cyclin C complex with phenylaminoquinoline scaffold. PeerJ 8, pages e8649.
Crossref
Mohamed A. Said, Wagdy M. Eldehna, Alessio Nocentini, Samar H. Fahim, Alessandro Bonardi, Abdullah A. Elgazar, Vladimír Kryštof, Dalia H. Soliman, Hatem A. Abdel-Aziz, Paola Gratteri, Sahar M. Abou-Seri & Claudiu T. Supuran. (2020) Sulfonamide-based ring-fused analogues for CAN508 as novel carbonic anhydrase inhibitors endowed with antitumor activity: Design, synthesis, and in vitro biological evaluation. European Journal of Medicinal Chemistry 189, pages 112019.
Crossref
Mohamed A. Said, Wagdy M. Eldehna, Alessio Nocentini, Alessandro Bonardi, Samar H. Fahim, Silvia Bua, Dalia H. Soliman, Hatem A. Abdel-Aziz, Paola Gratteri, Sahar M. Abou-Seri & Claudiu T. Supuran. (2020) Synthesis, biological and molecular dynamics investigations with a series of triazolopyrimidine/triazole-based benzenesulfonamides as novel carbonic anhydrase inhibitors. European Journal of Medicinal Chemistry 185, pages 111843.
Crossref
Mahmoud F. Abo-Ashour, Wagdy M. Eldehna, Alessio Nocentini, Alessandro Bonardi, Silvia Bua, Hany S. Ibrahim, Mahmoud M. Elaasser, Vladimír Kryštof, Radek Jorda, Paola Gratteri, Sahar M. Abou-Seri & Claudiu T. Supuran. (2019) 3-Hydrazinoisatin-based benzenesulfonamides as novel carbonic anhydrase inhibitors endowed with anticancer activity: Synthesis, in vitro biological evaluation and in silico insights. European Journal of Medicinal Chemistry 184, pages 111768.
Crossref